The incidence of sunlight-induced skin cancer is increasing. Mouse studies indicate that caffeine, administered orally or topically, promotes apoptosis of UVB-irradiated keratinocytes. In this issue, Heffernan and colleagues identify the pathway targeted by caffeine and suggest that inhibition of this DNA damage response may offer a viable therapeutic option for nonmelanoma skin cancer. This potentially represents an important protective or therapeutic option from the most unlikely of sources: your daily coffee.
. One mechanism that may explain this effect is the apparent ability of caffeine to selectively induce apoptosis in UV-damaged keratinocytes. "Normal" human skin carries clonal patches of p53-mutated keratinocytes. These are enriched by sun exposure, indicating that p53-mutated keratinocytes may be more resistant to UV-induced apoptosis (Jonason et al., 1996) . Crucially, caffeine-induced potentiation of apoptosis in this context appears to be independent of p53. The biological effects of caffeine are complex. Caffeine (in amounts in the millimolar range) can inhibit both ATR and the related ataxiatelangiectasia-mutated (ATM) kinase, both of which are central components of the DNA damage response. ATM is activated by DNA double-strand breaks, whereas ATR is preferentially activated by single-stranded regions of DNA, which can occur at stalled DNA replication forks or as intermediates during NER of UV photoproducts (O'Driscoll et al., 2003) . But much of the work concerning caffeine and ATR/ATM has traditionally used either primary and transformed fibroblasts or tumor-derived cell lines such as HeLa, 293T, and U2OS.
In this issue, Heffernan and colleagues report the combined impact of caffeine and UVB radiation on a physiologically relevant target, namely, primary human keratinocytes (HKCs). This is important not only because nonmelanoma skin cancers arise from these cells but also because keratinocytes respond to UVB differently than do skin fibroblasts, as discussed in Heffernan et al. The authors report that caffeine (2 mM) induced an apoptotic response following UVB irradiation at 75 mJ/cm within 8 hours, as indicated by caspase-3 and PARP cleavage. Caffeine is also a known inhibitor kinase ATR (ataxia telangiectasia and Rad3-related). Mutations in ATR in humans are associated with Seckel syndrome, a developmental disorder characterized by microcephaly and proportionate growth retardation (O'Driscoll et al., 2003) . ATR-mutated Seckel syndrome primary skin fibroblasts exhibit decreased survival following UV irrad iation (O'Driscoll et al., 2003) . ATR phosphorylates several proteins, including the histone H2A variant H2AX, p53, and Brca1. Chk1 kinase is an important effector and substrate of ATR. Chk1 plays a key role in mediating replication fork stability following DNA damage and is also required for cell cycle checkpoint activation (Chen and Sanchez, 2004) . In fact, selective inhibitors of Chk1, such as UCN-01, are being investigated in the clinic for combinational therapies with other DNA-damaging agents against various malignancies.
There is growing molecular, cellular, and epidemiological evidence to suggest that caffeine, even in its most recognizable form in tea and coffee, may have a significant protective effect against UV-induced carcinogenesis in mice and humans (Abel et al., 2007; Hakim et al., 2000 Relentless depletion of the ozone layer, climate change, increased recreational sun exposure, and even the use of UV tanning beds probably contribute to the increasing incidence of nonmelanoma skin cancer. Much of the mutagenic and carcinogenic potential of UV radiation is a consequence of DNA damage (e.g., 6-4 pyrimidine-pyrimadone photoproducts and cyclobutane pyrimidine dimers). These forms of DNA damage are efficiently recognized and removed by the nucleotide excision repair (NER) pathway, a DNA repair pathway conserved from bacteria to humans. Congenital defects in this pathway in humans result in a variety of complex disorders, including xeroderma pigmento sum, Cockayne's syndrome, and trichothiodystrophy, all of which feature sunlight sensitivity and, particularly in the case of xeroderma pigmentosum, a predisposition to cancer in sun-exposed areas. UV-induced DNA damage also induces multiple signal transduction networks that coordinate cell cycle checkpoint arrest and even apoptosis induction. An important pathway activated in response to UV is the phosphoinositol-3-kinase-like protein of cAMP phosphodiesterase, which, when inhibited, results in increased intra cellular levels of cAMP.
Using dibutyryl-cAMP, a cellpermeable cAMP analog, Heffernan and colleagues determined that the apoptotic effects of caffeine following UVB in HKCs are unlikely to be mediated via cAMP phosphodiesterdase inhibition. Not surprisingly, they reported that UVB activates the ATR-Chk1 pathway in HKCs (Figure 1 ), as indicated by increased phospho-serine-345-Chk1. Interestingly, this phosphorylation was attenuated by caffeine. In fact, siRNA of ATR, but not that of the related kinase ATM, in HKCs augmented UVB-induced apoptosis, mimicking the effect of caffeine in these cells. Importantly, caffeine did not further enhance UVB-induced apoptosis following siRNA of ATR in HKCs, indicating that caffeine's effects are epistatic to those of ATR-pathway inhibition. Furthermore, Heffernan and colleagues reported that treatment of HKCs with PF610666, a novel Chk1 kinase inhibitor that appears to be more selective than UCN-01, the archetypal Chk1 inhibitor, similarly potentiated UVB-induced apoptosis (Heffernan et al., 2009; Blasina et al., 2008) . Collectively, these data strongly indicate that the ATR-Chk1 pathway may represent the main biologically relevant target of caffeine in HKCs.
Of particular note, Heffernan et al. also reported that the ability of ATR inhibition to enhance UVB-induced apoptosis was independent of p53 status in HKCs, raising the intriguing suggestion that administration of an ATR-pathway inhibitor, such as a selective Chk1 inhibitor or, indeed, caffeine, may provide protection against the DNA-damaging impact of UVB on skin. In support of this, Lu et al. (2008) recently demonstrated that oral administration of caffeine in millimolar concentrations to mice markedly inhibited UVB-induced Chk1 phosphorylation on serine 345 in the epidermis, indicating that, at least in this animal model, the ATR-Chk1 pathway can be inhibited in the relevant target tissue by administration of caffeine at tolerable doses. Previously, Lu et al. (2002) had demonstrated that topical application of caffeine to mice enhanced the elimination of p53-mutated keratinocytes from skin. The work by Heffernan et al. described in this issue provides a molecular explanation for these important observations. This apparent paradox raised by Heffernan and colleagues-that of inhibiting a DNA-damage response pathway to protect against the adverse impact of a DNA-damaging agent (i.e., UVB)-should stimulate investigation of the practical applications of ATR-pathway inhibition in HKCs for the prevention of nonmelanoma skin cancer. An inborn deficit in ATRpathway function results in a severe developmental disorder in humans. Whereas gene targeting of ATR in mice results in early embryonic lethality prior to gastrulation, indicating the essential role of ATR during development, knockdown of ATR in somatic cells results in pronounced genomic instability, particularly DNA fragilesite expression. Indeed, conditional deletion of ATR in adult mice has a profound impact on the homeostasis of many different tissues, including skin, indicating that there may be a long way to go before we can determine the precise conditions whereby ATR-pathway inhibition is protective or beneficial (Ruzankina et al., 2007) . Nevertheless, the suggestion proffered by Heffernan and colleagues of a topical formulation containing an ATR-Chk1 pathway inhibitor applied directly to the target tissue (i.e., skin) cleverly circumvents the potential "off-target" side effects that would be predicted by a systemic inhibition of this important DNA-damage response pathway.
Considering the role of ATR in maintaining genomic stability, the long-term impact of ATR-pathway inhibition in HKCs, specifically with respect to potential secondary tumor formation, is one issue that will need to be addressed, but the work by Heffernan and colleagues provides a definite starting point. Ironically, one important compound that could help here has been under our noses for years, namely, caffeine. Selective inhibition of Chk1 kinase using PF610666 mimics the effect of caffeine in these cells. UVB irradiation has been shown to enhance selection for p53-mutated HKCs in sun-exposed skin (cells with black nuclei). Because UV-induced transformation of HKCs results in nonmelanoma skin cancer, the findings of Heffernan and colleagues raise the intriguing possibility that application of an ATR-pathway inhibitor such as caffeine may be protective against UVB radiation by augmenting the apoptotic elimination of UVB-damaged HKCs independently of p53 status (gray cells).
